Health
New target for drug development could fill a major gap in depression treatment – News-Medical.net – Port Macquarie Online News
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects.
THE IDEAVanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression.The research was led by Lisa Monteggia,……
Continue Reading
-
General24 hours agoFire razes Tumby Bay hardware store with damage likely to exceed $1m
-
Noosa News23 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
Business8 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News12 hours agoThe postcodes where rent chews up half your pay cheque